TNF and inflammatory bowel disease: Since approval was granted for an anti-TNF-α antibody drug, anti-TNF-α therapy has been the first-line treatment for moderate to severe cases of IBD because it induces intestinal epithelium recovery and ameliorates clinical symptoms [10].